WATCH: How OTC medicine was just what the doctor ordered for Adcock

Adcock Ingram announced on Wednesday that turnover had increased by 10%, despite the price-regulated environment in which it operates. It reported that operating profit was up 21%, fuelled by its over-the-counter division, and headline earnings per share (HEPS) from continuing operations rose 26%. Adcock Ingram CEO Andrew Hall spoke to Business Day TV to provide more detail on the results.

OR LISTEN TO THE AUDIO:..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Subscribe Sign in

Cancel anytime.

Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

SIGN UP

SIGN IN

Please read our Comment Policy before commenting.